indazoles has been researched along with Gout in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, SG; Gowda, K; Hubbard, TD; Kuzu, G; Lahoti, TS; Muku, GE; Murray, IA; Perdew, GH; Podolsky, MA; Smith, KJ | 1 |
| Füessl, HS; Stiefelhagen, P | 1 |
2 other study(ies) available for indazoles and Gout
| Article | Year |
|---|---|
Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses.
Topics: Allyl Compounds; Animals; Cells, Cultured; Cytoplasm; Disease Models, Animal; Gout; Indazoles; Inflammation; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Knockout; Receptors, Aryl Hydrocarbon | 2017 |
[Frequent gout attacks during therapy - what can be done?].
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Colchicine; Drug Therapy, Combination; Gout; Gout Suppressants; Humans; Indazoles; Kidney Neoplasms; Male; Pyrimidines; Sulfonamides | 2013 |